NCT07319429 2026-03-13
FEMUS
Fudan University
Phase 2/3 Recruiting
Clinical Trials
13 trialsNCT07462663 2026-03-10
SHAPE-ENDO
Hospital Universitari de Bellvitge
Not yet recruiting
NCT05651282 2025-08-29
RESToRE
University of British Columbia
Phase 4 Active not recruiting
NCT05247268 2025-04-06
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
Fudan University
Phase 2 Recruiting
NCT05255653 2024-11-29
RAINBO
Leiden University Medical Center
Phase 2/3 Recruiting
NCT06549855 2024-08-12
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Peking University People's Hospital
Phase NA Not yet recruiting
NCT05675787 2024-07-11
Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Peking University People's Hospital
Phase 2 Recruiting
NCT00577122 2023-10-16
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
Indiana University
Phase 2 Completed
NCT00743574 2021-08-13
Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)
Yale University
Phase NA Completed
NCT01718444 2020-09-29
Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)
University of Illinois at Chicago
Phase NA Terminated
NCT01607320 2018-09-20
PCOS
Prisma Health-Upstate
Phase NA Terminated
NCT03567655 2018-06-26
Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer
Asan Medical Center
Phase 2 Unknown
NCT00291369 2006-02-16
Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis
Centre Leon Berard
Phase 3 Completed